It widely agreed that we need to identify better methods of detecting lung earlier. There has been great data suggesting the use of low-dose CT scans for screening. However, can the benefits of this screening be carried over into the clinic? Here, Neal Navani, PhD, of University College London Hospitals NHS Foundation Trust, London, UK, discusses the issue, including whether many countries will have the healthcare resources required. This video was recorded at the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland.
Can we translate the benefits of lung cancer screening to the clinic?
